LAG3 antibody (M02869-1) performs well in ELISA, Flow Cytometry, IF, IHC-P, ICC, WB and shows reactivity with Human.

  • Validated for inter-lot consistency, specificity, and reproducibility
  • Committed to quality since 1993
Filter:
m02869 1 lag3 primary antibodies fcm testing 6m02869 1 lag3 primary antibodies if testing 3m02869 1 lag3 primary antibodies if testing 4m02869 1 lag3 primary antibodies ihc testing 5m02869 1 lag3 primary antibodies icc testing 2m02869 1 lag3 primary antibodies wb testing 1m02869 1 lag3 primary antibodies elisa testing 7m02869 1 lag3 primary antibodies elisa testing 8

Anti-LAG3 Monoclonal Antibody [2G8]

LAG3 antibody

Reactive SpeciesHostApplication
HumanMouseELISA, Flow Cytometry, IF, IHC-P, ICC, WB

SKU: M02869-1

Size: 0.1 mg

Bundle to save: I do not want free secondary ab
Price:
$481/0.1 mg

In stock. Ships Next Business Day.

Quantity: 1

1
Get A Quote
Guarantee / Product Promise

Recommend Dilution

Application
Dilution
Species
LAG-3 antibody can be used for ELISA starting at 0.25 μg/mL. For Western blot start at 0.25 μg/mL. For Immunocytochemistry start at 1 μg/mL. For Immunofluorescence start at 10 μg/mL. For Immunohistochemistry start at 5 μg/mL. For Flow Cytometry start at 1 μg/ml.
Antibody validated: Western Blot in human samples; Immunohistochemistry in human samples; Immunocytochemistry in human samples; Immunofluorescence in human samples and Flow Cytometry in human samples. All other applications and species not yet tested. Optimal dilutions for each application should be determined by the researcher.

* It is recommended to optimize the amount of this reagent in each experimental system to achieve the best results.

Product Information

Product Name
Anti-LAG3 Monoclonal Antibody [2G8]
View all LAG3 Antibodies
Form
Liquid
Uniprot
Gene ID
Storage & Handling
LAG-3 antibody can be stored at 4°C for three months and -20°C, stable for up to one year. Avoid repeated freeze-thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
Host
Mouse
Contents
LAG-3 Antibody is supplied in PBS containing 0.02% sodium azide and 50% glycerol.
Clonality
Monoclonal
Clone Number
Clone: 2G8
Isotype
IgG1,k
Immunogen
LAG-3 antibody was raised against the extracellular domain of human LAG-3
Observed Molecular Weight
68 kDa
Calculated Molecular Weight

57.4 kDa

Background of LAG3
The lymphocyte activation gene-3 (LAG3) is a member of the immunoglobulin superfamily and binds MHC class II with high affinity (1), negatively regulating T-cell function and homeostasis (2). It is expressed in B, T, and NK cells, monocytes, and dendritic cells (3), and acts to regulate T cell expansion (4). LAG3 is also an important immune checkpoint protein, with anti-LAG3 antibodies activating T effector cells and affecting regulatory T cell functions. Furthermore LAG3 appears to act in a synergistic fashion with PD-1/PD-L1, suggesting that a dual antibody approach may prove useful in cancer immunotherapy.
Cite This Product
Anti-LAG3 Monoclonal Antibody [2G8] (Boster Biological Technology, Pleasanton CA, USA, Catalog # M02869-1)

Review

Have you used Anti-LAG3 Monoclonal Antibody [2G8]?

Submit a review and receive $370 in product credits, a $185 Amazon gift card, or our carefully curated gift bundles.

Product Promise

We promise Anti-LAG3 Monoclonal Antibody [2G8] performs excellently in relevant applications for ELISA, Flow Cytometry, IF, IHC-P, ICC, WB. If it doesn't perform as promised, we will refund the product. Learn more

In stock
Order Product
M02869-1
Buy one primary antibody get one 0.5ml HRP or Biotin secondary antibody for free.
*Sample sizes are prepared on demand and will take extra lead time. (cannot be conjugated)
$481.00

Troubleshooting

troubleshooting-box-image

Download troubleshooting handbooks for IHC, Western blot and ELISA for FREE.

Download Free PDFs Now

Boster Guarantee

Guaranteed product quality

Guaranteed product quality

We promise all of our products perform as described in datasheets.

This product is for Research Use Only. Not for use in diagnostic procedures.

Update date: Oct 10, 2026